Correlation Between Novacyt and Biosynex
Can any of the company-specific risk be diversified away by investing in both Novacyt and Biosynex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novacyt and Biosynex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novacyt and Biosynex, you can compare the effects of market volatilities on Novacyt and Biosynex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novacyt with a short position of Biosynex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novacyt and Biosynex.
Diversification Opportunities for Novacyt and Biosynex
Poor diversification
The 3 months correlation between Novacyt and Biosynex is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Novacyt and Biosynex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biosynex and Novacyt is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novacyt are associated (or correlated) with Biosynex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biosynex has no effect on the direction of Novacyt i.e., Novacyt and Biosynex go up and down completely randomly.
Pair Corralation between Novacyt and Biosynex
Assuming the 90 days trading horizon Novacyt is expected to generate 1.33 times more return on investment than Biosynex. However, Novacyt is 1.33 times more volatile than Biosynex. It trades about -0.17 of its potential returns per unit of risk. Biosynex is currently generating about -0.25 per unit of risk. If you would invest 108.00 in Novacyt on August 31, 2024 and sell it today you would lose (50.00) from holding Novacyt or give up 46.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Novacyt vs. Biosynex
Performance |
Timeline |
Novacyt |
Biosynex |
Novacyt and Biosynex Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novacyt and Biosynex
The main advantage of trading using opposite Novacyt and Biosynex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novacyt position performs unexpectedly, Biosynex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosynex will offset losses from the drop in Biosynex's long position.The idea behind Novacyt and Biosynex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |